Age of the Donor Reduces the Ability of Human Adipose-Derived Stem Cells to Alleviate Symptoms in the Experimental Autoimmune Encephalomyelitis Mouse Model

There is a significant clinical need for effective therapies for primary progressive multiple sclerosis, which presents later in life (i.e., older than 50 years) and has symptoms that increase in severity without remission. With autologous mesenchymal stem cell therapy now in the early phases of cli...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Scruggs, Brittni A., Semon, Julie A., Zhang, Xiujuan, Zhang, Shijia, Bowles, Annie C., Pandey, Amitabh C., Imhof, Kathleen M.P., Kalueff, Allan V., Gimble, Jeffrey M., Bunnell, Bruce A.
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2013
Sujets:
Tissue Engineering and Regenerative Medicine
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3785264/
https://ncbi.nlm.nih.gov/pubmed/24018793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5966/sctm.2013-0026
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires